中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2015年
11期
994-998
,共5页
杨倩%齐晓勇%党懿%宋学莲%郝潇
楊倩%齊曉勇%黨懿%宋學蓮%郝瀟
양천%제효용%당의%송학련%학소
心房颤动%降血脂药%Meta分析
心房顫動%降血脂藥%Meta分析
심방전동%강혈지약%Meta분석
Atrial fibrillation%Antilipemic agents%Meta-analysis
目的 评价他汀类药物对持续性心房颤动(AF)患者经电复律转复为窦性心律后复发的影响.方法 检索PubMed、EMBase和Cochrane central register of controlled trials数据库,获取从建库至2015年2月发表的对比他汀类药物组与对照组电复律后AF复发率的随机对照试验.采用RevMan5.3和State12.0软件进行荟萃分析.结果 纳入文献6篇,共572例患者.荟萃分析显示:持续性AF患者经电复律转复为窦性心律后,他汀类药物组与对照组之间的AF复发率差异无统计学意义(OR=0.60,95%CI:0.32~1.11,P>0.05);对纳入试验中应用阿托伐他汀治疗的4个试验进行亚组分析,结果 显示他汀类药物组与对照组之间的电复律后AF复发率差异无统计学意义(OR=0.59,95%CI:O.25~1.39,P>0.05);对纳入试验中质量高的3个试验(Jadad评分≥3分)进行亚组分析,结果 亦显示他汀类药物组与对照组之间的电复律后AF复发率差异无统计学意义(OR=0.76,95%CI:0.49~1.16,P>0.05).结论 荟萃分析表明,持续性AF患者经电复律转复为窦性心律后,应用他汀类药物治疗对AF的复发无影响.
目的 評價他汀類藥物對持續性心房顫動(AF)患者經電複律轉複為竇性心律後複髮的影響.方法 檢索PubMed、EMBase和Cochrane central register of controlled trials數據庫,穫取從建庫至2015年2月髮錶的對比他汀類藥物組與對照組電複律後AF複髮率的隨機對照試驗.採用RevMan5.3和State12.0軟件進行薈萃分析.結果 納入文獻6篇,共572例患者.薈萃分析顯示:持續性AF患者經電複律轉複為竇性心律後,他汀類藥物組與對照組之間的AF複髮率差異無統計學意義(OR=0.60,95%CI:0.32~1.11,P>0.05);對納入試驗中應用阿託伐他汀治療的4箇試驗進行亞組分析,結果 顯示他汀類藥物組與對照組之間的電複律後AF複髮率差異無統計學意義(OR=0.59,95%CI:O.25~1.39,P>0.05);對納入試驗中質量高的3箇試驗(Jadad評分≥3分)進行亞組分析,結果 亦顯示他汀類藥物組與對照組之間的電複律後AF複髮率差異無統計學意義(OR=0.76,95%CI:0.49~1.16,P>0.05).結論 薈萃分析錶明,持續性AF患者經電複律轉複為竇性心律後,應用他汀類藥物治療對AF的複髮無影響.
목적 평개타정류약물대지속성심방전동(AF)환자경전복률전복위두성심률후복발적영향.방법 검색PubMed、EMBase화Cochrane central register of controlled trials수거고,획취종건고지2015년2월발표적대비타정류약물조여대조조전복률후AF복발솔적수궤대조시험.채용RevMan5.3화State12.0연건진행회췌분석.결과 납입문헌6편,공572례환자.회췌분석현시:지속성AF환자경전복률전복위두성심률후,타정류약물조여대조조지간적AF복발솔차이무통계학의의(OR=0.60,95%CI:0.32~1.11,P>0.05);대납입시험중응용아탁벌타정치료적4개시험진행아조분석,결과 현시타정류약물조여대조조지간적전복률후AF복발솔차이무통계학의의(OR=0.59,95%CI:O.25~1.39,P>0.05);대납입시험중질량고적3개시험(Jadad평분≥3분)진행아조분석,결과 역현시타정류약물조여대조조지간적전복률후AF복발솔차이무통계학의의(OR=0.76,95%CI:0.49~1.16,P>0.05).결론 회췌분석표명,지속성AF환자경전복률전복위두성심률후,응용타정류약물치료대AF적복발무영향.
Objective To evaluate the impact of statin therapy on the recurrence rate in patients with persistent atrial fibrillation (AF) after electrical cardioversion.Methods PubMed,EMBbase,Cochrane central register of controlled trials were searched up to February 2015 to identify randomized controlled trials,which reported the effect of statin therapy on AF recurrence after electrical cardioversion.The data were analyzed by RevMan 5.3 and Stata 12.0 software.Results Six trials with 572 patients were included.The result showed that statin therapy had no effect on the recurrence rate in patients with persistent AF after electrical cardioversion (OR=0.60,95%CI:0.32-1.11,P>0.05) compared with controls.Four out of the six trials investigated the effect of atorvastatin on the recurrence rate of AF after electrical cardioversion,subgroup analysis of these trials showed that compared with controls,atorvastatin had no effect on the recurrence of AF after electrical cardioversion (OR=0.59,95%CI:0.25-1.39,P>0.05).Three out of the six trials had high quality (Jadad score≥3),subgroup analysis of these trials also showed that statins did not affect the recurrence rate of AF after electrical cardioversion (OR=0.76,95%CI:0.49-1.16,P>0.05).Conclusion This analysis suggested that statin therapy had no effect on the recurrence rate in patients with persistent AF after electrical cardioversion.